Date: October 01, 2026
Other Operational / Legal / Strategic Disclosures
Lupin Limited disclosed the completion of a share buyback by its step-down subsidiary Multicare Pharmaceuticals Philippines, Inc. (MPPI). MPPI is a subsidiary of Nanomi B.V., Netherlands, which is a wholly owned subsidiary of Lupin Limited.
The buyback involved 30,559 shares, which represented the remaining balance of shares not owned by the company. This transaction follows a previous intimation made on July 01, 2026.
Effective October 01, 2026, MPPI has become a wholly owned subsidiary of Nanomi B.V. and consequently a step-down wholly owned subsidiary of Lupin Limited.
The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and was signed by Amit Kumar Gupta, Company Secretary & Compliance Officer (ACS -15754).